Injectable, anti-collapse, adhesive, plastic and bioactive bone graft substitute promotes bone regeneration by moderating oxidative stress in osteoporotic bone defect
Acta Biomaterialia · 2024-05 · 180 · 82-103
DOI: 10.1016/j.actbio.2024.04.016 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Biomaterialia, 2024-05. Verfasst von Lei Huang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Surgery, Zhongshan Hospital, Fudan University, Shanghai, 200032, China. Hauptthemen laut MEDLINE: Oxidative Stress, Bone Substitutes, Bone Regeneration, Osteoporosis. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Natural Science Foundation of Shanghai Municipality, Fudan University, National Natural Science Foundation of China.
Abstract (Originalsprache)
The treatment of osteoporotic bone defect remains a big clinical challenge because osteoporosis (OP) is associated with oxidative stress and high levels of reactive oxygen species (ROS), a condition detrimental for bone formation. Anti-oxidative nanomaterials such as selenium nanoparticles (SeNPs) have positive effect on osteogenesis owing to their pleiotropic pharmacological activity which can exert anti-oxidative stress functions to prevent bone loss and facilitate bone regeneration in OP. In the current study a strategy of one-pot method by introducing Poly (lactic acid-carbonate) (PDT) and β-Tricalcium Phosphate (β-TCP) with SeNPs, is developed to prepare an injectable, anti-collapse, shape-adaptive and adhesive bone graft substitute material (PDT-TCP-SE). The PDT-TCP-SE bone graft substitute exhibits sufficient adhesion in biological microenvironments and osteoinductive activity, angiogenic effect and anti-inflammatory as well as anti-oxidative effect in vitro and in vivo. Moreover, the PDT-TCP-SE can protect BMSCs from erastin-induced ferroptosis through the Sirt1/Nrf2/GPX4 antioxidant pathway, which, in together, demonstrated the bone graft substitute material as an emerging biomaterial with potential clinical application for the future treatment of osteoporotic bone defect. STATEMENT OF SIGNIFICANCE: Injectable, anti-collapse, adhesive, plastic and bioactive bone graft substitute was successfully synthesized. Incorporation of SeNPs with PDT into β-TCP regenerated new bone in-situ by moderating oxidative stress in osteoporotic bone defects area. The PDT-TCP-SE bone graft substitute reduced high ROS levels in osteoporotic bone defect microenvironment. The bone graft substitute could also moderate oxidative stress and inhibit ferroptosis via Sirt1/Nrf2/GPX4 pathway in vitro. Moreover, the PDT-TCP-SE bone graft substitute could alleviate the inflammatory environment and promote bone regeneration in osteoporotic bone defect in vivo. This biomaterial has the advantages of simple synthesis, biocompatibility, anti-collapse, injectable, and regulation of oxidative stress level, which has potential application value in bone tissue engineering.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedic Surgery, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
- The Key Laboratory for Ultrafine Materials of Ministry of Education, Frontiers Science Center for Materiobiology and Dynamic Chemistry, Engineering Research Center for Biomedical Materials of Ministry of Education, Scho…
- School of Medicine and Dentistry, Griffith University, Gold Coast, QLD 4222, Australia.
- Department of Orthopedic Surgery, Zhongshan Hospital, Fudan University, Shanghai, 200032, China. Electronic address: jiang.libo@zs-hospital.sh.cn.
- Department of Orthopedic Surgery, Zhongshan Hospital, Fudan University, Shanghai, 200032, China. Electronic address: zhang.jian@zs-hospital.sh.cn.
Förderung
- Natural Science Foundation of Shanghai Municipality
- Fudan University
- National Natural Science Foundation of China
- Science and Technology Commission of Shanghai Municipality
- National Key Research and Development Program of China
Zitieren
APA
Huang, L., Zhang, S., Bian, M., Xiang, X., Xiao, L., Wang, J., Lu, S., Chen, W., Zhang, C., Mo, G., Jiang, L., Li, Y., & Zhang, J. (2024). Injectable, anti-collapse, adhesive, plastic and bioactive bone graft substitute promotes bone regeneration by moderating oxidative stress in osteoporotic bone defect. Acta Biomaterialia, 180, 82-103. https://doi.org/10.1016/j.actbio.2024.04.016
Vancouver
Huang L, Zhang S, Bian M, Xiang X, Xiao L, Wang J, et al. Injectable, anti-collapse, adhesive, plastic and bioactive bone graft substitute promotes bone regeneration by moderating oxidative stress in osteoporotic bone defect. Acta Biomaterialia. 2024;180:82-103. doi:10.1016/j.actbio.2024.04.016
BibTeX
@article{Huang2024,
author = {Huang, Lei and Zhang, Shihao and Bian, Mengxuan and Xiang, Xingdong and Xiao, Lan and Wang, Jiayi and Lu, Shunyi and Chen, Weisin and Zhang, Cheng and Mo, Guokang and Jiang, Libo and Li, Yulin and Zhang, Jian},
title = {Injectable, anti-collapse, adhesive, plastic and bioactive bone graft substitute promotes bone regeneration by moderating oxidative stress in osteoporotic bone defect},
journal = {Acta Biomaterialia},
year = {2024},
volume = {180},
pages = {82--103},
doi = {10.1016/j.actbio.2024.04.016}
}
EUVIMED